Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Xuxue Ye"'
Autor:
Lihao Zhao, Xiaona Cai, Didi Chen, Xuxue Ye, Mengdan Gao, Lihuai Lu, Huafang Su, Meng Su, Meng Hou, Congying Xie
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2019)
Abstract Background The development of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has dramatically improved the prognosis of patients with EGFR-mutant non-small-cell lung cancer (NSCLC). The purpose of this study is to in
Externí odkaz:
https://doaj.org/article/c95e3301473d41efaed1e59b33af22e8
Autor:
Linger Liu, Zhenghua Fei, Mengfeng Chen, Lihao Zhao, Huafang Su, Dianna Gu, Baochai Lin, Xiaona Cai, Lihuai Lu, Mengdan Gao, Xuxue Ye, Xiance Jin, Congying Xie
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Abstract Background In the era of intensity-modulated radiotherapy (IMRT), the role of additional concurrent chemotherapy (CC) to radiotherapy (RT) after induction chemotherapy (IC) compared to IC followed by RT alone remains unclear for stage II-IVB
Externí odkaz:
https://doaj.org/article/225468a22be3402880b45d690e830e47
Autor:
Ya Gao, Xiaona Cai, Xuxue Ye, Xiaohua Zhang, Lihao Zhao, Huafang Su, Didi Chen, Qingyu Zhou, Congying Xie, Meng Su
Publikováno v:
OncoTargets and Therapy. 12:9707-9713
Purpose Apatinib is effective and safe for several advanced or metastatic cancers, but its therapeutic value in cervical cancer is still unknown. The aim of the study was to assess the therapeutic value of apatinib in patients with chemo-refractory a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::219870ef845b83b76aa842d275fa2e16
https://doi.org/10.2147/ott.s230406
https://doi.org/10.2147/ott.s230406
Autor:
Xuxue Ye, Mengdan Gao, Xiaona Cai, Meng Hou, Didi Chen, Huafang Su, Lihao Zhao, Lihuai Lu, Meng Su, Congying Xie
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-8 (2019)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background The development of epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) has dramatically improved the prognosis of patients with EGFR-mutant non-small-cell lung cancer (NSCLC). The purpose of this study is to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ede83e1752b226289a0ecb1160892ce
https://doi.org/10.1186/s13014-019-1454-2
https://doi.org/10.1186/s13014-019-1454-2
Autor:
Meng, Su, Ya, Gao, XuXue, Ye, QingYu, Zhou, LiHao, Zhao, Xiaona, Cai, Didi, Chen, Huafang, Su, Xiaohua, Zhang, Congying, Xie
Publikováno v:
OncoTargets and therapy
Purpose Apatinib is effective and safe for several advanced or metastatic cancers, but its therapeutic value in cervical cancer is still unknown. The aim of the study was to assess the therapeutic value of apatinib in patients with chemo-refractory a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::10c7a2cd6159f0b49b9d46d1034c630c
https://pubmed.ncbi.nlm.nih.gov/32009803
https://pubmed.ncbi.nlm.nih.gov/32009803
Autor:
Baochai Lin, Zhenghua Fei, Xiaona Cai, Congying Xie, Mengfeng Chen, Huafang Su, Lihao Zhao, Xiance Jin, Linger Liu, Dianna Gu, Mengdan Gao, Xuxue Ye, Lihuai Lu
Publikováno v:
Radiation Oncology, Vol 13, Iss 1, Pp 1-9 (2018)
Radiation Oncology (London, England)
Radiation Oncology (London, England)
Background In the era of intensity-modulated radiotherapy (IMRT), the role of additional concurrent chemotherapy (CC) to radiotherapy (RT) after induction chemotherapy (IC) compared to IC followed by RT alone remains unclear for stage II-IVB nasophar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8389799a94aaa0ffd1817d8376d3c9ba
https://doi.org/10.1186/s13014-018-1092-0
https://doi.org/10.1186/s13014-018-1092-0
Autor:
Xiaona Cai, Linger Liu, Xiance Jin, Xuxue Ye, Mengdan Gao, Mengfeng Chen, Dianna Gu, Lihuai Lu, Didi Chen, Congying Xie
Publikováno v:
International Journal of Medical Sciences
Background and Objectives: Colorectal cancer is one of the most common cancers and the leading cause of cancer-related death worldwide. The impact of the primary tumor location on the prognosis of patients with colorectal cancer has long been a conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb8ee374e3995dbea9dfc3817be6b2d2
https://pubmed.ncbi.nlm.nih.gov/30588187
https://pubmed.ncbi.nlm.nih.gov/30588187